Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

548 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dermoscopic features of difficult melanoma.
Pizzichetta MA, Stanganelli I, Bono R, Soyer HP, Magi S, Canzonieri V, Lanzanova G, Annessi G, Massone C, Cerroni L, Talamini R; Italian Melanoma Intergroup (IMI). Pizzichetta MA, et al. Among authors: talamini r. Dermatol Surg. 2007 Jan;33(1):91-9. doi: 10.1111/j.1524-4725.2007.33015.x. Dermatol Surg. 2007. PMID: 17214687
Negative pigment network: an additional dermoscopic feature for the diagnosis of melanoma.
Pizzichetta MA, Talamini R, Marghoob AA, Soyer HP, Argenziano G, Bono R, Corradin MT, De Giorgi V, Gonzalez MA, Kolm I, Kopf AW, Malvehy J, Nami N, Oliviero M, Pellacani G, Puig S, Rabinovitz H, Rubegni P, Seidenari S, Stanganelli I, Veronesi A, Zalaudek I, Zampieri P, Menzies SW. Pizzichetta MA, et al. Among authors: talamini r. J Am Acad Dermatol. 2013 Apr;68(4):552-559. doi: 10.1016/j.jaad.2012.08.012. Epub 2012 Oct 9. J Am Acad Dermatol. 2013. PMID: 23062610
Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet.
Argenziano G, Soyer HP, Chimenti S, Talamini R, Corona R, Sera F, Binder M, Cerroni L, De Rosa G, Ferrara G, Hofmann-Wellenhof R, Landthaler M, Menzies SW, Pehamberger H, Piccolo D, Rabinovitz HS, Schiffner R, Staibano S, Stolz W, Bartenjev I, Blum A, Braun R, Cabo H, Carli P, De Giorgi V, Fleming MG, Grichnik JM, Grin CM, Halpern AC, Johr R, Katz B, Kenet RO, Kittler H, Kreusch J, Malvehy J, Mazzocchetti G, Oliviero M, Ozdemir F, Peris K, Perotti R, Perusquia A, Pizzichetta MA, Puig S, Rao B, Rubegni P, Saida T, Scalvenzi M, Seidenari S, Stanganelli I, Tanaka M, Westerhoff K, Wolf IH, Braun-Falco O, Kerl H, Nishikawa T, Wolff K, Kopf AW. Argenziano G, et al. Among authors: talamini r. J Am Acad Dermatol. 2003 May;48(5):679-93. doi: 10.1067/mjd.2003.281. J Am Acad Dermatol. 2003. PMID: 12734496 Review.
A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies.
Muraro E, Martorelli D, Turchet E, Miolo G, Scalone S, Comaro E, Talamini R, Mastorci K, Lombardi D, Perin T, Carbone A, Veronesi A, Crivellari D, Dolcetti R. Muraro E, et al. Among authors: talamini r. Breast Cancer Res. 2011;13(6):R117. doi: 10.1186/bcr3060. Breast Cancer Res. 2011. PMID: 22112244 Free PMC article.
548 results